A Review on Bladder Tumor Antigens
Obeagu Emmanuel Ifeanyi
Additional contact information
Obeagu Emmanuel Ifeanyi: Department of University Health Services, Michael Okpara University of Agriculture, Nigeria
Cancer Therapy & Oncology International Journal, 2018, vol. 9, issue 3, 72-83
Abstract:
The bladder is a hollow organ in the pelvis with flexible, muscular walls. Its main function is to store urine before it leaves the body. Urine is made by the kidneys and is then carried to the bladder through tubes called ureters. The bladder is an organ located in the lower abdominal area near the pelvic bones that acts as a reservoir for urine. Almost all bladder cancers originate in the urothelium, which is a 3- to 7-cell mucosal layer within the muscular bladder. Squamous cell carcinoma of the bladder can involve multiple sites; however, the lateral wall and trigone are more commonly involved by this tumor. All small cell carcinomas of the urinary system identified so far have been located in the urinary bladder, most commonly in the dome and vesical lateral wall. Bladder cancer begins when cells in the urinary bladder start to grow uncontrollably. As more cancer cells develop, they can form a tumor and spread to other areas of the body. Normally, cells in the body will grow and divide to replace old or damaged cells in the body. This growth is highly regulated, and once enough cells are produced to replace the old ones, normal cells stop dividing. Tumors occur when there is an error in this regulation and cells continue to grow in an uncontrolled way. Tumors can either be benign or malignant. Cytological examination of urine (looking for abnormal cells in urine) has been the most commonly tested screening tool. Routine urinalysis, performed as part of normal health maintenance, will detect any presence of blood in the urine.
Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555762.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555762.php (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:9:y:2018:i:3:p:72-83
DOI: 10.19080/CTOIJ.2018.09.555762
Access Statistics for this article
Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis
More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().